相似文献
1
Testicular germ cell tumours--a model for a new approach to treatment of adult solid tumours.
Postgrad Med J. 1985 Feb;61(712):123-31. doi: 10.1136/pgmj.61.712.123.
2
Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
Neth J Surg. 1983 Jul;35(3):89-93.
3
[Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
Vopr Onkol. 1988;34(12):1493-7.
4
Testicular carcinoma. A curable malignancy.
Acta Radiol Oncol. 1985 Jan-Feb;24(1):3-15. doi: 10.3109/02841868509134359.
5
Rare cancers and specialist centres.
Br Med J (Clin Res Ed). 1986 Mar 8;292(6521):641-2. doi: 10.1136/bmj.292.6521.641.
6
Combination chemotherapy in the treatment of germ cell tumors containing choriocarcinoma in males and females.
Surg Gynecol Obstet. 1972 Jan;134(1):61-6.
7
Operative and cytostatic treatment of germinal tumours of the testis.
Int Urol Nephrol. 1973 Jan;5(1):85-95. doi: 10.1007/BF02081754.
8
[The results of combined treatment for testicular tumours. Report of 12 cases (author's transl)].
J Urol (Paris). 1982;88(2):97-9.
9
Experiences with the treatment of malignant tumours of the testis.
Neoplasma. 1971;18(1):113-22.
10
Treatment of locoregional germ cell tumor.
Prog Clin Biol Res. 1990;350:295-9.
引用本文的文献
1
Recent trends in mortality due to testicular cancer in Ireland: a comparison with England and Wales.
J Epidemiol Community Health. 1986 Sep;40(3):218-22. doi: 10.1136/jech.40.3.218.
2
Testicular self-examination: is it still necessary.
Postgrad Med J. 1988 Mar;64(749):250. doi: 10.1136/pgmj.64.749.250.
3
Findings in lymph nodes of patients with germ cell tumours after chemotherapy and their relation to prognosis.
J Clin Pathol. 1989 Oct;42(10):1049-54. doi: 10.1136/jcp.42.10.1049.
4
Prognosis of testicular tumour since the introduction of complex therapy.
Int Urol Nephrol. 1989;21(1):81-9. doi: 10.1007/BF02549905.
5
Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.
Int Urol Nephrol. 1989;21(2):175-84. doi: 10.1007/BF02550806.
本文引用的文献
1
Nitrogen mustard therapy in Hodgkin's disease; analysis of 50 consecutive cases.
Blood. 1949 Apr;4(4):338-79.
2
Radiotherapy and testicular neoplasms.
Lancet. 1951 Dec 29;2(6696):1195-7. doi: 10.1016/s0140-6736(51)93202-3.
3
Tumors of the testis.
J Urol. 1959 Mar;81(3):457-61. doi: 10.1016/S0022-5347(17)66042-7.
4
Therapy of metastatic trophoblastic tumors of the testis.
Am J Med Sci. 1959 Jan;237(1):42-8. doi: 10.1097/00000441-195901000-00006.
5
Chemotherapy of advanced malignant teratomas.
Br J Cancer. 1980 Sep;42(3):378-91. doi: 10.1038/bjc.1980.248.
6
VP16-213 as a single agent in advanced testicular tumors.
Eur J Cancer (1965). 1980 Sep;16(9):1193-7. doi: 10.1016/0014-2964(80)90178-4.
7
Placental alkaline phosphatase as a tumor marker for seminoma.
Cancer Res. 1982 Aug;42(8):3244-7.
8
The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture.
Cancer. 1981 Jan 1;47(1):1-13. doi: 10.1002/1097-0142(19810101)47:1<1::aid-cncr2820470102>3.0.co;2-2.
9
Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumours.
Br J Urol. 1983 Dec;55(6):764-8. doi: 10.1111/j.1464-410x.1983.tb03422.x.
10
Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis.
Br J Urol. 1983 Dec;55(6):760-3. doi: 10.1111/j.1464-410x.1983.tb03421.x.
Zotero 插件